KORU Medical Systems, Inc. (KRMD)
USD 2.31
(0.66%)
USD 2.31
(0.66%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.44 Million USD | -9.74% |
| 2022 | 4.92 Million USD | 715.21% |
| 2021 | 604.13 Thousand USD | 152.26% |
| 2020 | 239.49 Thousand USD | -37.25% |
| 2019 | 381.67 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 439.3 Thousand USD | -9.01% |
| 2011 | 482.8 Thousand USD | 8710.22% |
| 2010 | 5480.00 USD | -99.21% |
| 2009 | 689.96 Thousand USD | -14.29% |
| 2008 | 804.98 Thousand USD | -4.8% |
| 2007 | 845.54 Thousand USD | -8.78% |
| 2006 | 926.89 Thousand USD | 24.34% |
| 2005 | 745.44 Thousand USD | 8.82% |
| 2004 | 685.01 Thousand USD | 14.26% |
| 2003 | 599.5 Thousand USD | 68.61% |
| 2002 | 355.56 Thousand USD | 2.84% |
| 2001 | 345.74 Thousand USD | 223.04% |
| 2000 | 107.02 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 3.96 Million USD | -4.93% |
| 2024 Q1 | 4.17 Million USD | -6.14% |
| 2023 Q1 | 4.6 Million USD | -6.58% |
| 2023 Q3 | 4.62 Million USD | 8.3% |
| 2023 Q2 | 4.27 Million USD | -7.15% |
| 2023 FY | 4.44 Million USD | -9.74% |
| 2023 Q4 | 4.44 Million USD | -3.92% |
| 2022 Q3 | 5.05 Million USD | 11.43% |
| 2022 FY | 4.92 Million USD | 715.21% |
| 2022 Q4 | 4.92 Million USD | -2.63% |
| 2022 Q1 | 4.56 Million USD | 655.61% |
| 2022 Q2 | 4.53 Million USD | -0.56% |
| 2021 Q1 | 203.44 Thousand USD | -15.05% |
| 2021 Q2 | 167.51 Thousand USD | -17.66% |
| 2021 Q4 | 604.13 Thousand USD | -24.93% |
| 2021 Q3 | 804.77 Thousand USD | 380.43% |
| 2021 FY | 604.13 Thousand USD | 152.26% |
| 2020 Q3 | 275.11 Thousand USD | -92.78% |
| 2020 Q2 | 3.81 Million USD | 106.39% |
| 2020 Q4 | 239.49 Thousand USD | -12.95% |
| 2020 FY | 239.49 Thousand USD | -37.25% |
| 2020 Q1 | 1.84 Million USD | 383.71% |
| 2019 Q1 | 477.55 Thousand USD | 0.0% |
| 2019 Q3 | 410.19 Thousand USD | -7.63% |
| 2019 Q4 | 381.67 Thousand USD | -6.95% |
| 2019 FY | 381.67 Thousand USD | 0.0% |
| 2019 Q2 | 444.07 Thousand USD | -7.01% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | -100.0% |
| 2013 Q1 | 439.3 Thousand USD | 21777.79% |
| 2012 Q1 | 482.8 Thousand USD | -2.12% |
| 2012 Q3 | 2532.00 USD | -99.46% |
| 2012 FY | 439.3 Thousand USD | -9.01% |
| 2012 Q2 | 472.17 Thousand USD | -2.2% |
| 2012 Q4 | 2008.00 USD | -20.7% |
| 2011 Q4 | 493.26 Thousand USD | -2.05% |
| 2011 FY | 482.8 Thousand USD | 8710.22% |
| 2011 Q2 | 513.73 Thousand USD | 9274.74% |
| 2011 Q1 | 5480.00 USD | -98.97% |
| 2011 Q3 | 503.58 Thousand USD | -1.98% |
| 2010 Q1 | 689.96 Thousand USD | -1.49% |
| 2010 FY | 5480.00 USD | -99.21% |
| 2010 Q4 | 533.59 Thousand USD | -1.79% |
| 2010 Q3 | 543.29 Thousand USD | -16.78% |
| 2010 Q2 | 652.85 Thousand USD | -5.38% |
| 2009 Q3 | 705.48 Thousand USD | -11.3% |
| 2009 Q4 | 700.4 Thousand USD | -0.72% |
| 2009 FY | 689.96 Thousand USD | -14.29% |
| 2009 Q1 | 804.98 Thousand USD | -0.19% |
| 2009 Q2 | 795.37 Thousand USD | -1.19% |
| 2008 Q3 | 837.78 Thousand USD | -0.6% |
| 2008 FY | 804.98 Thousand USD | -4.8% |
| 2008 Q4 | 806.48 Thousand USD | -3.74% |
| 2008 Q2 | 842.87 Thousand USD | -0.32% |
| 2008 Q1 | 845.54 Thousand USD | -10.34% |
| 2007 FY | 845.54 Thousand USD | -8.78% |
| 2007 Q4 | 943.03 Thousand USD | 2.17% |
| 2007 Q3 | 923.03 Thousand USD | 0.11% |
| 2007 Q2 | 922.02 Thousand USD | -0.53% |
| 2007 Q1 | 926.89 Thousand USD | -0.9% |
| 2006 Q4 | 935.29 Thousand USD | -2.03% |
| 2006 Q1 | 745.44 Thousand USD | 0.21% |
| 2006 FY | 926.89 Thousand USD | 24.34% |
| 2006 Q2 | 790 Thousand USD | 5.98% |
| 2006 Q3 | 954.69 Thousand USD | 20.85% |
| 2005 Q3 | 752.7 Thousand USD | -0.56% |
| 2005 Q2 | 756.92 Thousand USD | 10.5% |
| 2005 Q1 | 685.01 Thousand USD | 0.11% |
| 2005 Q4 | 743.85 Thousand USD | -1.17% |
| 2005 FY | 745.44 Thousand USD | 8.82% |
| 2004 Q2 | 693.59 Thousand USD | 15.69% |
| 2004 Q1 | 599.5 Thousand USD | 51.71% |
| 2004 FY | 685.01 Thousand USD | 14.26% |
| 2004 Q4 | 684.26 Thousand USD | -0.66% |
| 2004 Q3 | 688.82 Thousand USD | -0.69% |
| 2003 Q2 | 405.03 Thousand USD | 13.91% |
| 2003 Q1 | 355.56 Thousand USD | 7.15% |
| 2003 Q4 | 395.16 Thousand USD | 3.74% |
| 2003 Q3 | 380.93 Thousand USD | -5.95% |
| 2003 FY | 599.5 Thousand USD | 68.61% |
| 2002 Q1 | 345.74 Thousand USD | 23.32% |
| 2002 Q2 | 378.68 Thousand USD | 9.53% |
| 2002 Q3 | 339.94 Thousand USD | -10.23% |
| 2002 Q4 | 331.82 Thousand USD | -2.39% |
| 2002 FY | 355.56 Thousand USD | 2.84% |
| 2001 Q2 | 208.32 Thousand USD | 94.64% |
| 2001 Q3 | 262.99 Thousand USD | 26.24% |
| 2001 Q4 | 280.36 Thousand USD | 6.6% |
| 2001 Q1 | 107.02 Thousand USD | -3.89% |
| 2001 FY | 345.74 Thousand USD | 223.04% |
| 2000 Q4 | 111.36 Thousand USD | 0.0% |
| 2000 FY | 107.02 Thousand USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 94.814% |
| AngioDynamics, Inc. | 5.91 Million USD | 24.837% |
| AtriCure, Inc. | 74.49 Million USD | 94.033% |
| Avinger, Inc. | 15.39 Million USD | 71.126% |
| Azenta, Inc. | 60.43 Million USD | 92.645% |
| BioLife Solutions, Inc. | 42.69 Million USD | 89.588% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 99.827% |
| Daxor Corporation | 755.65 Thousand USD | -488.244% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | 37.987% |
| Femasys Inc. | 6.7 Million USD | 33.664% |
| GlucoTrack, Inc. | 196 Thousand USD | -2167.918% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 89.608% |
| Hologic, Inc. | 2.53 Billion USD | 99.825% |
| ICU Medical, Inc. | 1.7 Billion USD | 99.739% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 95.05% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | 76.721% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 99.542% |
| Microbot Medical Inc. | 231 Thousand USD | -1824.294% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | 39.367% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 99.501% |
| Nephros, Inc. | 1.83 Million USD | -142.109% |
| NovoCure Limited | 596.24 Million USD | 99.254% |
| NEXGEL, Inc. | 2.79 Million USD | -58.868% |
| NEXGEL, Inc. | 2.79 Million USD | -58.868% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 94.096% |
| OraSure Technologies, Inc. | 13.5 Million USD | 67.083% |
| Pro-Dex, Inc. | 13.54 Million USD | 67.187% |
| Pulse Biosciences, Inc. | 9.14 Million USD | 51.388% |
| Predictive Oncology Inc. | 2.85 Million USD | -55.597% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -29.427% |
| QuidelOrtho Corporation | 2.61 Billion USD | 99.83% |
| Repligen Corporation | 711.8 Million USD | 99.376% |
| Sanara MedTech Inc. | 11.79 Million USD | 62.304% |
| STAAR Surgical Company | 35.83 Million USD | 87.595% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -1199.743% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.807% |
| Jin Medical International Ltd. | 4.11 Million USD | -8.075% |